The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study with a CNS-penetrant, selective ALK inhibitor alectinib in ALK-rearranged non-small cell lung cancer (ALK+ NSCLC) patients (pts): Updates on progression free survival (PFS) and safety results from AF-001JP.
 
Yuichiro Ohe
Honoraria - Chugai Pharma; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Chugai Pharma; Novartis; Roche Pharma AG
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Makoto Nishio
Consulting or Advisory Role - Chugai Pharma; Novartis; Pfizer
Speakers' Bureau - Chugai Pharma; Nicholas Piramal; Pfizer
Research Funding - Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Katsuyuki Kiura
Speakers' Bureau - Astellas Pharma; Chugai Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Takashi Seto
Speakers' Bureau - Chugai Pharma; Pfizer
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Kazuhiko Nakagawa
Speakers' Bureau - Astellas Pharma; Chugai Pharma; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Makoto Maemondo
Speakers' Bureau - Chugai Pharma; Novartis; Pfizer
 
Akira Inoue
Speakers' Bureau - Chugai Pharma
 
Toyoaki Hida
Speakers' Bureau - Chugai Pharma; Pfizer
Research Funding - Chugai Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Hiroshige Yoshioka
Speakers' Bureau - Chugai Pharma
 
Masao Harada
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma (Inst)
 
Naoyuki Nogami
Speakers' Bureau - Chugai Pharma; Pfizer
Research Funding - Chugai Pharma (Inst); Pfizer (Inst)
 
Haruyasu Murakami
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Chugai Pharma; Pfizer
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Novartis (Inst)
 
Kengo Takeuchi
Consulting or Advisory Role - Chugai Pharma; Nichirei
Speakers' Bureau - Chugai Pharma; Nichirei; Pfizer; Ventana Medical Systems
Research Funding - Chugai Pharma (Inst); Nichirei (Inst)
Patents, Royalties, Other Intellectual Property - Nichirei; Nichirei (Inst)
 
Tadashi Shimada
Employment - Chugai Pharma
 
Hiroshi Kuriki
Employment - Chugai Pharma
Stock and Other Ownership Interests - Chugai Pharma
 
Tomohiro Tanaka
Employment - Chugai Pharma
 
Tomohide Tamura
Speakers' Bureau - Astellas Pharma; Chugai Pharma; Novartis; Pfizer; Roche Pharma AG